MEP7809A - Nova primjena docetaksela za liječenje hepatoma - Google Patents

Nova primjena docetaksela za liječenje hepatoma

Info

Publication number
MEP7809A
MEP7809A MEP-78/09A MEP7809A MEP7809A ME P7809 A MEP7809 A ME P7809A ME P7809 A MEP7809 A ME P7809A ME P7809 A MEP7809 A ME P7809A
Authority
ME
Montenegro
Prior art keywords
docetaxel
hepatocellular carcinoma
treating hepatocellular
present
treating
Prior art date
Application number
MEP-78/09A
Other languages
English (en)
Inventor
Chin-Wen Chi
Heng-Liang Lin
Tsung-Yun Liu
Wing-Yiu Lui
Gar-Yang Chau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ME00624B publication Critical patent/ME00624B/me
Publication of MEP7809A publication Critical patent/MEP7809A/bs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Ovaj pronalazak se zasniva na nalazu da je docetaksel znatno akti vniji proti v ćelija hepatoćelijskih karcinoma od paklitaksela pri koncentracijama do 1 μM. Prema tome ovaj pronalazak daje primjenu docetaksela ili njegovog hidrata u proizvodnji lijeka za primjenu u liječenju hepatoćelijskog karcinoma.
MEP-78/09A 1999-08-31 2000-08-29 Nova primjena docetaksela za liječenje hepatoma MEP7809A (bs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9920548.6A GB9920548D0 (en) 1999-08-31 1999-08-31 Treatment of hepatocellular carcinoma
PCT/EP2000/008782 WO2001015675A2 (en) 1999-08-31 2000-08-29 Use of docetaxel for treating hepatocellular carcinoma

Publications (2)

Publication Number Publication Date
ME00624B ME00624B (me) 2011-12-20
MEP7809A true MEP7809A (bs) 2011-12-20

Family

ID=10860081

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-78/09A MEP7809A (bs) 1999-08-31 2000-08-29 Nova primjena docetaksela za liječenje hepatoma

Country Status (34)

Country Link
US (2) US20030158249A1 (bs)
EP (1) EP1214061B1 (bs)
JP (1) JP4866522B2 (bs)
KR (1) KR100670416B1 (bs)
CN (1) CN1174748C (bs)
AT (1) ATE269700T1 (bs)
AU (1) AU777583B2 (bs)
BG (1) BG65913B1 (bs)
BR (1) BR0013625A (bs)
CA (1) CA2382294C (bs)
CZ (1) CZ301378B6 (bs)
DE (1) DE60011794T2 (bs)
DK (1) DK1214061T3 (bs)
EA (1) EA004804B1 (bs)
EE (1) EE05124B1 (bs)
ES (1) ES2218223T3 (bs)
GB (1) GB9920548D0 (bs)
HK (1) HK1048944B (bs)
HR (1) HRP20020171A2 (bs)
HU (1) HU228861B1 (bs)
IL (2) IL147489A0 (bs)
ME (1) MEP7809A (bs)
MX (1) MXPA02002041A (bs)
NO (1) NO328527B1 (bs)
NZ (1) NZ517604A (bs)
PL (1) PL212612B1 (bs)
PT (1) PT1214061E (bs)
RS (1) RS50148B (bs)
SI (1) SI1214061T1 (bs)
SK (1) SK286378B6 (bs)
TW (1) TW589180B (bs)
UA (1) UA72927C2 (bs)
WO (1) WO2001015675A2 (bs)
ZA (1) ZA200201408B (bs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1268619C (zh) 2003-05-08 2006-08-09 上海迪赛诺化学制药有限公司 多烯紫杉醇三水化合物的制备方法
ATE427943T1 (de) * 2003-12-12 2009-04-15 Quiral Quimica Do Brasil Verfahren zur herstellung von wasserfreien und hydratisierten pharmazeutischen wirkstoffen (apis); aus diesen hergestellte stabile pharmazeutische zusammensetzungen und anwendungen fur diese zusammensetzungen
US7449196B2 (en) * 2004-07-09 2008-11-11 Robert Sabin Anti tumor compositions and methods of use
NZ592132A (en) * 2005-08-31 2012-12-21 Abraxis Bioscience Llc Composition comprising nanoparticles of docitaxel and a citrate
EP2404594B1 (en) * 2005-08-31 2017-12-20 Abraxis BioScience, LLC Compositions comprising docetaxel with increased stability
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US20080081051A1 (en) * 2006-09-28 2008-04-03 Robert Sabin Method of manufacturing anti-tumor and anti-viral compositions
EP2146695A4 (en) * 2007-04-23 2010-05-19 Sun Pharmaceuticals Ind Ltd PHARMACEUTICAL COMPOSITIONS
FR2917088B1 (fr) * 2007-06-08 2009-09-04 Aventis Pharma Sa Dissolution directe du docetaxel dans un solvant dans le polysorbate 80
US8541360B2 (en) * 2008-11-19 2013-09-24 Ben Venue Laboratories, Inc. Parenteral formulations comprising sugar-based esters and ethers
ES2675212T3 (es) 2010-03-26 2018-07-09 Abraxis Bioscience, Llc Métodos de tratamiento de carcinoma hepatocelular
WO2011139899A2 (en) * 2010-05-03 2011-11-10 Teikoku Pharma Usa, Inc. Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
US8842114B1 (en) 2011-04-29 2014-09-23 Nvidia Corporation System, method, and computer program product for adjusting a depth of displayed objects within a region of a display
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
WO2016134066A1 (en) * 2015-02-17 2016-08-25 Mallinckrodt Llc Modified docetaxel liposome formulations and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2629819B1 (fr) * 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
US5543154A (en) * 1991-12-27 1996-08-06 Merck & Co., Inc. Controlled release nifedipine delivery device
CA2150372C (en) * 1993-01-19 2002-08-20 Nancy L. Mills Stable oral ci-981 formulation and process of preparing same
US5801029A (en) * 1993-02-16 1998-09-01 Onyx Pharmaceuticals, Inc. Cytopathic viruses for therapy and prophylaxis of neoplasia
US5436243A (en) * 1993-11-17 1995-07-25 Research Triangle Institute Duke University Aminoanthraquinone derivatives to combat multidrug resistance
FR2718963B1 (fr) * 1994-04-25 1996-05-24 Rhone Poulenc Rorer Sa Nouvelle composition pharmaceutique à base de taxoïdes.
FR2722191B1 (fr) * 1994-07-08 1996-08-23 Rhone Poulenc Rorer Sa Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
US5968972A (en) 1995-10-26 1999-10-19 Baker Norton Pharmaceuticals, Inc. Method for increasing the oral bioactivity of pharmaceutical agents
US6245805B1 (en) * 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
FR2742751B1 (fr) * 1995-12-22 1998-01-30 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
US6503893B2 (en) * 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
DE69737510T2 (de) * 1996-12-30 2007-12-06 Battelle Memorial Institute, Columbus Verwendung eines unverkapselten Antikrebs-Arzneimittels zur Herstellung einer Zubereitung zur Behandlung von Neoplasmen durch Inhalation
CA2294981C (en) * 1997-06-27 2012-04-03 Vivorx Pharmaceuticals, Inc. Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
ATE233104T1 (de) * 1997-09-18 2003-03-15 Janssen Pharmaceutica Nv Kondensierte imidazolderivate zur erhöhung der oralen bioverfügbarkeit von pharmazeutika
AU1289899A (en) * 1997-10-31 1999-05-24 Arch Development Corporation Methods and compositions for regulation of 5-alpha reductase activity
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
JP2002533387A (ja) * 1998-12-23 2002-10-08 ジー．ディー．サール ＆ カンパニー 腫瘍治療の複合療法としてインテグリン拮抗物質と一つ以上の抗腫瘍剤を使用する方法
GB9909925D0 (en) * 1999-04-29 1999-06-30 Pharmacia & Upjohn Spa Combined preparations comprising anthracycline derivatives
BRPI0610344A2 (pt) * 2005-12-13 2016-11-29 Teva Pharma forma cristalizada do atorvastatin hemi-calcium, processo para sua preparação, produto famacêutico derivado e seu uso medicinal

Also Published As

Publication number Publication date
ME00624B (me) 2011-12-20
IL147489A0 (en) 2002-08-14
NZ517604A (en) 2004-04-30
ES2218223T3 (es) 2004-11-16
AU777583B2 (en) 2004-10-21
HRP20020171A2 (en) 2004-02-29
JP4866522B2 (ja) 2012-02-01
CN1372466A (zh) 2002-10-02
HU228861B1 (hu) 2013-06-28
US20030158249A1 (en) 2003-08-21
CA2382294C (en) 2008-06-03
HUP0203197A3 (en) 2005-01-28
BG106460A (bg) 2002-09-30
ZA200201408B (en) 2003-07-30
SI1214061T1 (en) 2004-12-31
DE60011794D1 (de) 2004-07-29
ATE269700T1 (de) 2004-07-15
AU7516800A (en) 2001-03-26
EE200200087A (et) 2003-04-15
KR100670416B1 (ko) 2007-01-17
EP1214061A2 (en) 2002-06-19
JP2003508427A (ja) 2003-03-04
PL212612B1 (pl) 2012-10-31
DK1214061T3 (da) 2004-11-01
NO20020829L (no) 2002-02-20
TW589180B (en) 2004-06-01
EA200200313A1 (ru) 2002-08-29
EE05124B1 (et) 2009-02-16
EP1214061B1 (en) 2004-06-23
WO2001015675A3 (en) 2001-09-20
HK1048944B (zh) 2005-04-22
RS50148B (sr) 2009-05-06
NO20020829D0 (no) 2002-02-20
WO2001015675A2 (en) 2001-03-08
MXPA02002041A (es) 2002-08-20
PT1214061E (pt) 2004-09-30
HK1048944A1 (en) 2003-04-25
CN1174748C (zh) 2004-11-10
US20080045584A1 (en) 2008-02-21
CZ301378B6 (cs) 2010-02-03
BR0013625A (pt) 2002-05-14
CA2382294A1 (en) 2001-03-08
BG65913B1 (bg) 2010-05-31
NO328527B1 (no) 2010-03-08
GB9920548D0 (en) 1999-11-03
SK286378B6 (sk) 2008-08-05
UA72927C2 (uk) 2005-05-16
YU11402A (sh) 2005-07-19
SK2712002A3 (en) 2002-07-02
IL147489A (en) 2006-06-11
DE60011794T2 (de) 2005-07-14
PL353198A1 (en) 2003-11-03
KR20020060166A (ko) 2002-07-16
CZ2002739A3 (cs) 2002-06-12
EA004804B1 (ru) 2004-08-26
HUP0203197A2 (hu) 2003-01-28

Similar Documents

Publication Publication Date Title
MEP7809A (bs) Nova primjena docetaksela za liječenje hepatoma
BRPI0414876A (pt) compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos
YU49101A (sh) Karboksiaril supstituisani difenil karbamidi kao inhibitori raf kinaze
DE60042153D1 (de) Pharmauzetisch zusammensetzung nitratenquelle und ansäuerungsmitteln enthaltende zur behandlung von offenen wunden und verbrennungen
MY147643A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
AR035482A1 (es) Uso de un compuesto de cianoquinolina para la manufactura de un medicamento para tratar o inhibir polipos colonicos
CY1107405T1 (el) Σyνθεση φεντανyλης για ρινικh χορhγηση
NO20034204D0 (no) Farmasöytiske kombinasjoner til behandling av kreft
ATE202931T1 (de) Taxanderivate enthaltende arzneizubereitungen
TR200003736T2 (tr) Anksiyete durumlarına ya da depresyona bağlı değişikliklerin önlenmesi
BR0209327A (pt) Composição para tratamento de constipação induzida por drogas
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
FR2825273B1 (fr) Composition pour le traitement des signes cutanes du vieillissement
BR0215336A (pt) Utilização de um composto ou um sal farmaceuticamente aceitável do mesmo, composto, e composição farmacêutica
RS50805B (sr) Upotreba fsh za lečenje neplodnosti
PT1206267E (pt) Medicamentos contendo oligo-ou/e polirribonucleotidos xenogenicos
DE60023321D1 (de) Zusammensetzung gegen Coccidiose
UY26735A1 (es) Métodos y composiciones para tratar flavivirus y pestivirus
ECSP972332A (es) Derivados de 6-fenilpiridil -2-amina
UA31078A (uk) Інгібітор вірусу імунодефіциту людини ( даримід )